top of page

Topic

Muscle Invasive Bladder Cancer (MIBC)

17 Podcasts • 1 Course on BackTable

Hear how experienced physicians manage Muscle Invasive Bladder Cancer (MIBC) on BackTable. Learn from podcasts, cases, and courses curated by physician content creators, covering diagnosis, clinical decision-making, and treatments. Get the BackTable app to follow this Topic and hear more of the conversations that matter to your practice.

GU Oncology: ASCO Highlights & Impacts on Practice
00:00 / 01:04

Save your progress. Continue watching on the BackTable app.

BackTable Tumor Board

Episode # 76  •  11 Aug 2026

GU Oncology: ASCO Highlights & Impacts on Practice

Is GU oncology entering a new era of early intensification and precision therapy? On this episode of the BackTable Tumor Board Podcast, Dr. Katy Beckermann and Dr. Alan Tan break down the latest GU oncology highlights from ASCO, including key updates in prostate, renal cell, and urothelial carcinoma. They discuss new data supporting HRR/BRCA-focused therapy in HSPC, the importance of early biomarker testing, and ongoing debates about overtreatment and real-world practice impact.

More on Muscle Invasive Bladder Cancer (MIBC)

Loading recent podcasts…

Tumor Board

Tumor Board # 76

Aug 10, 2026

with Dr. Alan Tan, Dr. Katy Beckermann

GU Oncology: ASCO Highlights & Impacts on Practice

Is GU oncology entering a new era of early intensification and precision therapy? On this episode of the BackTable...

​

Tumor Board

Tumor Board # 67

Jun 17, 2026

with Dr. Sunil Patel, Dr. Kristen Scarpato, Dr. Bogdana Schmidt

Bladder Cancer Risk Stratification: Best Practices

Why does up to 10% of bladder cancer pathology change on expert review, and what does that mean for your intermediate...

​

Tumor Board

Tumor Board # 54

Apr 6, 2026

with Dr. Tyler Stewart, Dr. Jun Gong

Clinical Advances in Muscle Invasive Bladder Cancer

Don’t miss the “curative window”! This episode takes a closer look at how evolving perioperative strategies and...

​

Tumor Board

Tumor Board # 45

Jan 26, 2026

with Dr. Amanda Nizam, Dr. Brad McGregor, Dr. Alan Tan

Urothelial Carcinoma: Understanding ctDNA & Precision Medicine

Is the era of cisplatin over, or are we simply becoming more precise about who benefits from it? As perioperative...

​

Urology

Urology # 316

Jul 13, 2026

with Dr. Adam Gadzinski, Dr. Ruchika Talwar

Bladder Cancer in the Community: Meeting Patients Where They Are

As bladder cancer treatment options expand, so do the challenges of delivering them in real-world practice. On this...

​

Urology

Urology # 310

Jun 17, 2026

with Dr. Sunil Patel, Dr. Kristen Scarpato, Dr. Bogdana Schmidt

Bladder Cancer Risk Stratification: Best Practices

Why does up to 10% of bladder cancer pathology change on expert review, and what does that mean for your intermediate...

1,300+ listens

Urology

Urology # 287

Jan 29, 2026

with Dr. Amanda Nizam, Dr. Brad McGregor, Dr. Alan Tan

Urothelial Carcinoma: Understanding ctDNA & Precision Medicine

Is the era of cisplatin over, or are we simply becoming more precise about who benefits from it? As perioperative...

1,500+ listens

Urology

Urology # 280

Dec 15, 2025

with Dr. Carissa Chu, Dr. Ruchika Talwar

Genomic Classifiers in Bladder Cancer Management

Can genomic classifiers close the gap between what we see and what a tumor will do? In this episode of BackTable...

1,100+ listens

Bladder Cancer Topics

Urology Course

2.5 hours, 43 lessons

The Materials available on BackTable are provided for informational and educational purposes only and are not a substitute for the independent professional judgment of a qualified healthcare professional in diagnosing or treating patients. Any opinions, statements, or views expressed are those of the individual contributors and do not necessarily reflect those of the publisher, platform, or any affiliated organization.

bottom of page